Clinical Trial Update: Evaluation Of Acceptability And Satisfaction Of Hemophilia Patients Treated With FusENGO

View source ↗

Summary

A completed clinical trial evaluating acceptability and satisfaction among hemophilia patients treated with FusENGO (Pfizer sponsor).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• FusENGO

Snippet

Sponsor: Pfizer | Conditions: Hemophilia A | Status: COMPLETED | Results posted: 2018-09-25